Urinary Bladder, Overactive
"Urinary Bladder, Overactive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
MeSH Number(s)
C12.777.829.866
C13.351.968.829.813
C23.888.942.343.780
Concept/Terms
Overactive Detrusor- Overactive Detrusor
- Detrusor, Overactive
- Overactive Detrusor Function
- Detrusor Function, Overactive
Below are MeSH descriptors whose meaning is more general than "Urinary Bladder, Overactive".
Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder, Overactive".
This graph shows the total number of publications written about "Urinary Bladder, Overactive" by people in Harvard Catalyst Profiles by year, and whether "Urinary Bladder, Overactive" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 0 | 3 |
| 2010 | 3 | 1 | 4 |
| 2011 | 2 | 1 | 3 |
| 2012 | 6 | 0 | 6 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 6 | 1 | 7 |
| 2017 | 2 | 2 | 4 |
| 2018 | 3 | 2 | 5 |
| 2019 | 2 | 2 | 4 |
| 2020 | 4 | 1 | 5 |
| 2021 | 6 | 0 | 6 |
| 2022 | 4 | 0 | 4 |
Below are the most recent publications written about "Urinary Bladder, Overactive" by people in Profiles.
-
Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings From a Randomized Trial. J Urol. 2023 01; 209(1):243-252.
-
A systematic review and in silico study of potential genetic markers implicated in cases of overactive bladder. Am J Obstet Gynecol. 2023 01; 228(1):36-47.e3.
-
Asynchronous telehealth visits for the treatment of overactive bladder. Menopause. 2022 06 01; 29(6):723-727.
-
Treatment of refractory overactive bladder with OnabotulinumtoxinA vs PTNS: TROOP trial. Int Urogynecol J. 2022 04; 33(4):851-860.
-
Reviving Cav1.2 as an attractive drug target to treat bladder dysfunction. FASEB J. 2022 01; 36(1):e22118.
-
De Novo Urinary Storage Symptoms Are Common after Radical Prostatectomy: Incidence, Natural History and Predictors. J Urol. 2022 Mar; 207(3):601-608.
-
A Scoping Review of the Economic Burden of Non-Cancerous Genitourinary Conditions. Urology. 2022 08; 166:29-38.
-
Onabotulinumtoxin A (Botox): A reasonable alternative for refractory neurogenic bladder dysfunction in children and young adults. Neurourol Urodyn. 2021 11; 40(8):1981-1988.
-
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug Saf. 2021 08; 44(8):899-915.
-
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. Curr Med Res Opin. 2021 05; 37(5):867-877.